PA
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.526
Exchange
XNAS - Nasdaq
-0.283
Last period CFO / Debt ratio ,USD
94%
CFO / Debt ratio has increased in 5 years
What is CFO / Debt ratio ?
CFO / Debt ratio is the ability of a company to pay off all of its debt obligations with cash generated from operating activities. The value 1 is the benchmark for Eyestock Rating calculation.
See also Pacific Biosciences
Company Analysis
PACB valuation, rating, competitors, insights and company profile
Eyestock Rating
PACB financial analysis by Eyestock methodology
Valuation
PACB valuation using historical relative method
Statements
PACB Income Statements, Balance Sheet and Cash Flow Statements
Dividends
PACB dividend yield and annual dividend
CFO / Debt ratio is the ability of a company to pay off all of its debt obligations with cash generated from operating activities. The value 1 is the benchmark for Eyestock Rating calculation.
Pacific Biosciences`s CFO / Debt ratio for the last twelve months ended 2024-06-30 is -0.283
